The US FDA has approved Moderna's next-generation COVID-19 vaccine for adults aged 65 and older, marking a significant stride ...

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

The US Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine, mNEXSPIKE, for individuals aged ...

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The FDA said on May 20 it planned to require drugmakers to test their Covid booster shots against an inert placebo in healthy ...

The shot is also cleared for individuals between 12 and 64 years of age who are at least one risk factor as defined by the ...

Just new variants of the coronavirus causing COVID are emerging, the US Food and Drug Administration (US FDA) has approved a ...

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention will ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...

The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according ...